Middle East & Africa Organ Preservation Market

Middle East and Africa Organ Preservation Market Size & Growth (2023 to 2028):

The Size of the Middle East & Africa Organ Preservation Market was valued at USD 17.33 million in 2023 and estimated to grow at a CAGR of 3.6%, to reach USD 20.68 million by 2028 during the forecast period 2023 to 2028.

Organ preservation's primary vital drivers are likely to be various technological developments and advancements throughout the organ transplantation and preservation industry. In addition, due to the increasing incidences of organ failure, the rapid rise of the elderly population, and many regional authorities are enacting favorable legislation.

The practice of keeping and maintaining organs donated for transplantation is known as organ preservation. In addition, they coordinate activities and public awareness campaigns to increase organ donors and transplant procedures throughout the region to fuel market growth.

With the growth in technological breakthroughs and improvements, this method involves cleaning the organ with a specific preservation solution depending on its demands and preserving it using various procedures necessary by the organ.

Also, due to the increase in the growing prevalence of chronic illnesses like chronic obstructive pulmonary diseases, disorders needing lung transplantation, and other target illnesses are driving the market growth. In addition, the increase in the growing elderly population is giving rise to the number of organ transplants and organ donors, and increasing measures and government initiatives to encourage organ donation are all driving the expansion of the organ preservation industry.

Market expansion is likely to be limited to some extent by the high cost of organ transplantation and religious concerns in particular countries. In addition, the large-scale costs associated with organ transplantation procedures limit procedure consumers to a smaller consumer base.

The lack of suitable donors and alternative modes of organ transplantation available in the market affects market growth. Also, limiting reimbursements for donating and transplanting organs can hurt the development of the organ preservation market.

This research report on the Middle East & Africa Organ Preservation Market has been segmented and sub-segmented into the following categories.

By Preservation Solution:

• UW
• Custodiol HTK
• Perfadex

By Transportation Technique:

• Static Cold Storage
• Hypothermic Machine Perfusion
• Normothermic Machine Perfusion

By Organ Type:

• Kidneys
• Liver
• lung

By Country:

• KSA
• UAE
• Israel
• the rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

The MEA market is expected to show significant growth in the market in the forecast period owing to the increase in the senior population in the region with the rise in the incidences of multi-organ failure with the increasing number of organ transplantation procedures in the market.

UAE organ preservation market and Saudi Arabia organ preservation market are expected to increase market growth in the forecasted years by developing new advancements in technology with an increase in government and non-government initiatives to encourage and spread awareness among people about donating organs. In addition, due to the rise in the prevalence of chronic diseases like cardiac vascular diseases, ischemic heart diseases in both regions are increasing the demand in the market.

South Africa organ preservation market is projected to witness a promising share in the organ preservation market in the following years. The market is estimated to be driven by the increase in chronic diseases. Also, kidney failure is expected to elevate the market growth of the organ preservation market as South Africa has over 11,718 prevalence rates as per the 100,000 population.

KEY MARKET PARTICIPANTS:

Key Market Companies leading the Middle East & Africa Organ Preservation Market Profiled in the Report are Essential Pharmaceuticals (U.S.), Dr. Franz Kohler Chemie GmbH (Germany), Organ Recovery Systems (U.S.), Xvivo Perfusion AB (Sweden), and Waters Medical Systems LLC (U.S.).